Nadir Benouali

Columbus, OH (USA)
Role(s):
Founder/Owner/Principal

DoseWatch Corporation

Location: Columbus
Industry: Healthcare
Year Founded: 2005
Number Employees: 1-10 people
Description: DoseWatch Corporation is a health care/IT startup. Our main focus is patient drug non-compliance which adds more than $100 billion in health care costs. Our technology is patented, and it offers quantifiable solutions to the treating physician, local pharmacist, insurance and pharmaceutical companies to detect patients' non-compliance with their treatment regimen. It consists of a smart blister card and a sophisticated software. Soon our technology will tell if you are taking your medications on time and as prescribed, the compliance information is linked in quasi-real time, no matter what geographical area you live in, to your physician, insurance company and much more. Think of its impact on the U.S. health care system. Also, our technology is aimed at the clinical trials where recruited patients often omit to take their drugs and filling the corresponding clinical data questionnaires. Soon the CRO and the EDC companies will find the needed solution in having clinical trials data transmitted in real time, thus saving time and costs along with reliable clinical trials' patients' behavior and compliance data. We are looking for solid partners/investors to embark into a multi-billion dollar opportunity! We are looking for a seed fund to help us produce a small quantity of smart blister cards and realize our own clinical trials to demonstrate its efficacy. We already have clients in Europe looking to purchase our technology for their clinical trials studies. An executive summary is available upon request.